Bifalgorithm post · Cancer in 2026: How Immunotherapy Is Reshaping the Odds · What the Report Means for Immunotherapy

Early Detection

Early Detection (Cancer in 2026: How Immunotherapy Is Reshaping the Odds · What the Report Means for Immunotherapy) — "Close the early detection gap: Cancer st…

Ideas in this flowchart

  • Close the early detection gap in cancer diagnosis
  • Cancer stage at diagnosis remains critical
  • Only 17% of pancreatic cancers are detected at the localized stage
  • Only 28% of lung cancers are detected at the localized stage
  • Lung cancer screening can reduce mortality by up to 24% in high-risk individuals
  • Only about 18% of eligible patients received lung cancer screening
  • Screening rates are lower among people under 60 and Native Americans
  • Screening among people under 60 was below 13%
  • Screening among Native Americans was 14%
  • Earlier detection gives immunotherapy its best chance to work
  • Localized lung cancer has 65% five-year survival, compared with 10% for distant-stage disease
Feed/

Early Detection

No cover

Channel

Cancer in 2026: How Immunotherapy Is Reshaping the Odds

1 page

"Close the early detection gap: Cancer stage at diagnosis remains critical – only 17% of pancreatic cancers and 28% of lung cancers are caught at the localized stage. Despite lung cancer screening reducing mortality by up to 24% in high-risk individuals, only about 18% of eligible patients received it, with even lower rates among those under 60 (<13%) and Native Americans (14%). Earlier detection gives immunotherapy its best chance to work, as localized lung cancer has 65% five-year survival compared to 10% for distant-stage disease."

Flowchart preview
👍
0
0 comments0 shares

Sign in to view and post comments.